July 3，Notice of the General Office of the National Development and Reform Commission on the cost of cost price surveys of some enterprises，involved 60 well -known pharmaceutical companies and listed pharmaceutical companies，Including GlaxoSmot (Tianjin) Co., Ltd.、Jiangsu Hengrui stake sports betting appStake Sports BettingPharmaceutical Co., Ltd.、Zhejiang Haizheng Pharmaceutical Co., Ltd.、Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Co., Ltd.、Yichang Renfu Pharmaceutical Co., Ltd.。
The National Development and Reform Commission said，According to the "Price Law of the People's Republic of China"、"Drug Management Law of the People's Republic of China" and the relevant provisions of the implementation regulations，In order to understand and master the cost in the process of drug production and circulation、Price and related situation，Make a timely formulation of adjusting the price of drugs，Decided to conduct cost price surveys on some enterprises。
This survey includes the price survey of the factory (port) and cost special survey，The main content of the former includes the company's 2012 government pricing pharmaceutical factory (port) price (port) and the basic situation of the financial management of manufacturers。The latter surveyed all the drug production for three consecutive years from 2010 to 2012、Sales、Cost cost and price related situation。
It is reported，Drug Price Review Center of the National Development and Reform Commission will form an investigation team，From July to October, we went to relevant enterprises to conduct field surveys。
Among these 60 pharmaceutical stake online sports bettingcompanies，My stake betting app10 listed pharmaceutical companies are famous，Including Hengrui Medicine、Keron Industry、Haizheng Pharmaceutical、Shanghai Kaibao、Yuheng Pharmaceutical、Southwest Pharmaceutical、Jinling Pharmaceutical、Shuanglu Pharmaceutical、Kunming Pharmaceutical and Northeast Pharmaceutical。
Reporter after statistics found，Among the My stake betting app10 listed pharmaceutical companies，7 companies achieved performance growth last year，Including Kellen Pharmaceutical、Hengrui Medicine、Shanghai Kaibao、Yuheng Pharmaceutical、Southwest Pharmaceutical、Northeast Pharmaceutical、Kunming Pharmaceutical, etc.。Among them, Coron Pharmaceutical、Hengrui Medicine、Haizheng Pharmaceutical、Shanghai Kaibao、Yuheng Pharmaceutical、Kunming Pharmaceutical and other companies realized the net profit attributable to the parent company to more than 100 million yuan last year。In the first quarter of this year，Except for the decline in the performance of Haizheng Pharmaceutical，The net profit of the remaining 9 companies has also achieved a year -on -year increase。and Northeast Pharmaceutical's performance has achieved growth，But still in a loss state，January to March this year，The company's net profit attributable stake betting appstake online sports bettingto the owner of the parent company is 26.07 million yuan，and last year the value was 76.98 million yuan。
In addition，High gross profit margin is also one of these My stake betting app10 listed pharmaceutical companies。iFind data display，Kunming Pharmaceutical、Southwest Pharmaceutical、The gross profit margin of many companies such as Kelun Pharmaceutical is more than 30%，The sales gross profit margin of Yuheng Pharmaceutical and Shuanglu Pharmaceutical is more than 60%，and Hengrui Medicine、Shanghai Kaibao's sales gross profit margin is as high as 83%。
Some people in the industry tell reporters，The price of drug prices may be related to the price reduction of drug prices。
In addition，Pharmaceutical companies surveyed by the National Development and Reform Commission also include some foreign pharmaceutical companies，For example, Glaxo Sonsk (Tianjin) Co., Ltd., etc.。Industry insiders told reporters，The price of imported drugs is also very different from the price of abroad，Some imported drugs have several times the domestic sales price and foreign sales prices，Imported drugs may become the key investigation object。
